Icb-1 Gene Expression is Elevated in Human Endometrial Adenocarcinoma and is Closely Associated With HER2 Expression

REFERENCES

• Johnson, A.L.; Aravind, L.; Shulzhenko, N.; Morgun, A.; Choi, S.Y.; Crockford, T.L.; Lambe, T.; Domaschenz, H.; Kucharska, E.M.; Zheng, L.; Vinuesa, C.G.; Lenardo, M.J.; Goodnow, C.C.; Cornall, R.J.; Schwartz R.H. Themis is a member of a new metazoan gene family and is required for the completion of thymocyte positive selection. Nat Immunol 2009, 10, 831–839.
   PubMed Web of Science ®Google Scholar
• Patrick, M.S.; Oda, H.; Hayakawa, K.; Sato, Y.; Eshima, K.; Kirikae, T.; Iemura, S.; Shirai, M.; Abe, T.; Natsume, T.; Sasazuki, T.; Suzuki H. Gasp, a Grb2-associating protein, is critical for positive selection of thymocytes. Proc Natl Acad Sci USA 2009, 106, 16345–16350.
   PubMed Web of Science ®Google Scholar
• Treeck, O.; Strunck, E.; Vollmer G. A novel basement membrane-induced gene identified in the human endometrial adenocarcinoma cell line HEC1B. FEBS Lett 1998, 425, 426–430.
   PubMed Web of Science ®Google Scholar
• Treeck, O.; Odani, T.; Itoh, N.; Imai, H.; Fujita, S.; Kohroki, J.; Nakanishi, T.; Diedrich, K.; Ortmann, O.; Tanaka, K.; Vollmer G. Detection of increased icb-1 transcript levels in maturing HL-60 cells: a novel marker for granulocytic and monocytic in vitro differentiation. Leuk Res 2002, 26, 765–769.
   PubMed Web of Science ®Google Scholar
• Treeck, O.; Kindzorra, I.; Pauser, K.; Treeck, L.; Ortmann O. Expression of icb-1 gene is interferon-gamma inducible in breast and ovarian cancer cell lines and affects the IFN gamma-response of SK-OV-3 ovarian cancer cells. Cytokine 2005, 32, 137–142.
   PubMed Web of Science ®Google Scholar
• Bollmann, J.; Ortmann, O.; Treeck O. Expression of differentiation-associated gene icb-1 is estrogen-responsive in ovarian and breast cancer cell lines. J Steroid Biochem Mol Biol 2008, 109, 16–21.
   PubMed Web of Science ®Google Scholar
• Konwisorz, A.; Springwald, A.; Haselberger, M.; Goerse, R.; Ortmann, O.; Treeck O. Knockdown of icb-1 gene enhanced estrogen responsiveness of ovarian and breast cancer cells. Endocr Relat Cancer 2010, 17(1), 147–157.
   Web of Science ®Google Scholar
• Springwald, A.; Lattrich, C.; Seitz, S.; Ortmann, O.; Treeck O. Single nucleotide polymorphisms in human gene icb-1 and breast cancer susceptibility. Cancer Invest 2009, 27, 669–672.
   PubMed Web of Science ®Google Scholar
• Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun M.J. Cancer statistics, 2008. CA Cancer J Clin 2008, 58, 71–96.
   PubMed Web of Science ®Google Scholar
• Lacey, J.V., Jr.; Mutter, G.L.; Ronnett, B.M.; Ioffe, O.B.; Duggan, M.A.; Rush, B.B.; Glass, A.G.; Richesson, D.A.; Chatterjee, N.; Langholz, B.; Sherman M.E. PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma. Cancer Res 2008, 68, 6014–6020.
   PubMed Web of Science ®Google Scholar
• Daikoku, T.; Hirota, Y.; Tranguch, S.; Joshi, A.R.; DeMayo, F.J.; Lydon, J.P.; Ellenson, L.H.; Dey S.K. Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice. Cancer Res 2008, 68, 5619–5627.
   PubMed Web of Science ®Google Scholar
• Hetzel, D.J.; Wilson, T.O.; Keeney, G.L.; Roche, P.C.; Cha, S.S.; Podratz K.C. HER-2/neu expression: a major prognostic factor in endometrial cancer. Gynecol Oncol 1992, 47, 179–185.
   PubMed Web of Science ®Google Scholar
• Wang, D.; Konishi, I.; Koshiyama, M.; Mandai, M.; Nanbu, Y.; Ishikawa, Y.; Mori, T.; Fujii S. Expression of c-erbB-2 protein and epidermal growth receptor in endometrial carcinomas. Correlation with clinicopathologic and sex steroid receptor status. Cancer 1993, 72, 2628–2637.
   PubMed Web of Science ®Google Scholar
• Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25, 402–408.
   PubMed Web of Science ®Google Scholar
• Saito, S.; Ito, K.; Nagase, S.; Suzuki, T.; Akahira, J.; Okamura, K.; Yaegashi, N.; Sasano H. Progesterone receptor isoforms as a prognostic marker in human endometrial carcinoma. Cancer Sci 2006, 97, 1308–1314.
   PubMed Web of Science ®Google Scholar
• Shih, H.C.; Shiozawa, T.; Kato, K.; Imai, T.; Miyamoto, T.; Uchikawa, J.; Nikaido, T.; Konishi I. Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator. Hum Pathol 2003, 34, 471–478.
   PubMed Web of Science ®Google Scholar
• Horree, N.; van Diest, P.J.; Van Der Groep, P.; Sie-Go, D.M.; Heintz A.P. Progressive derailment of cell cycle regulators in endometrial carcinogenesis. J Clin Pathol 2008, 61, 36–42.
   PubMed Web of Science ®Google Scholar
• Oreskovic, S.; Babic, D.; Kalafatic, D.; Barisic, D.; Beketic-Oreskovic L. A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma. Gynecol Oncol 2004, 93, 34–40.
   PubMed Web of Science ®Google Scholar
• Chakravarty, D.; Gupta, N.; Goda, J.S.; Srinivasan, R.; Patel, F.D.; Dhaliwal L. Steroid receptors, HER2/neu and Ki-67, in endometrioid type of endometrial carcinoma: correlation with conventional histomorphological features of prognosis. Acta Histochem 2010, 112(4), 355–363.
   Web of Science ®Google Scholar
• Uchikawa, J.; Shiozawa, T.; Shih, H.C.; Miyamoto, T.; Feng, Y.Z.; Kashima, H.; Oka, K.; Konishi I. Expression of steroid receptor coactivators and corepressors in human endometrial hyperplasia and carcinoma with relevance to steroid receptors and Ki-67 expression. Cancer 2003, 98, 2207–2213.
   PubMed Web of Science ®Google Scholar
• Ikawa, S.; Sano, T.; Furumoto, H.; Aono T. Multidirectional differentiation of endometrial carcinoma with special reference to tumor aggressiveness evaluated by Ki-67 expression. Gynecol Oncol 1999, 72, 323–330.
   PubMed Web of Science ®Google Scholar